Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Made-to-measure treatment battling colon cancer by computer

21.04.2006


Colon cancer treatment could be revolutionised with a pioneering computer system to help doctors fight the disease.



Colon cancer is the third biggest killer cancer and the £2 million EU-funded project could mean faster and more accurate diagnosis, leading to better treatment outcomes for patients.

The system identifies gene mutations that contribute to the growth of cancerous tumours, giving doctors vital details about the type of cancer and its possible causes. It works by matching information from a simple blood test to gene databases of other cases, equipping doctors with a valuable tool to make decisions on long-term care.


It helps them determine the most effective way to battle the condition and, by speeding up the time to make treatment decisions, it will boost survival rates and reduce costs incurred by inaccurate diagnosis. It also means patients will no longer need to undergo invasive procedures unnecessarily.

The project has been masterminded by a team across the EU, comprising leading computer experts working alongside cancer specialists, biomedical scientists and genetic engineers.

It heralds the first major step towards tailor-made, personalised medical treatment.

Dr Babak Akhgar leads the seven-strong team working on the project, in the University’s Cultural, Communication and Computing Research Institute. He said: "It’s very exciting. It is potentially a defining IT project for the future of cancer care and is a huge step towards cutting cancer rates across the board because once the system is established it can be adapted to be applied to other cancers. There’s a real chance of helping save lives. It harnesses the know-how in this field across Europe, bringing it to the desktop of any healthcare professional. It means treatment is backed up by hard facts, rather than reliant on a specialist’s interpretation and experience alone.

"It will be the first breakthrough in personalised medicine. It’s like being able to take a tablet not just for symptom relief, but to treat the exact illness you have. This paves the way for 25th century drugs that are tailor-made to treat an individual’s problems, rather than mass-produced drugs for all."

Sheffield Hallam University is one of eight research partners from across Europe working on the project, called MATCH. The state-of-the-art technology could be in use in hospitals within five years.

The next phase of MATCH is collecting data from colon cancer patient databases in Italy and Poland, which will be fed into the system and tested.

Pharmaceutical firms will also be brought into the project to feed into talks on potential new drug design and discoveries.

Kelly Hill | alfa
Further information:
http://www.shu.ac.uk/news

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

Im Focus: A molecular switch may serve as new target point for cancer and diabetes therapies

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.

Cell growth and cell differentiation as well as the release and efficacy of hormones such as insulin depend on the presence of lipids. Lipids are small...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

NRL's sun imaging telescopes fly on NASA Parker Solar Probe

13.08.2018 | Physics and Astronomy

UT-ORNL team makes first particle accelerator beam measurement in six dimensions

13.08.2018 | Physics and Astronomy

ASU astrophysicist helps discover that ultrahot planets have starlike atmospheres

13.08.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>